Inhibition of group B streptococcal growth by IFNγ-activated human glioblastoma cells

Journal of Neuroimmunology

Volumn 89, Issue 1-2, 1998, Pages 191-197

  MacKenzie, Colin R ^a   Willberg, Christian B ^a   Däubener, Walter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Group B streptococci; IDO; Immunology of CNS infections; L tryptophan; Meningitis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; KYNURENINE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRYPTOPHAN;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASTROCYTOMA; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; NERVE CELL CULTURE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

GLIOBLASTOMA; HUMANS; INTERFERON TYPE II; MENINGITIS, BACTERIAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; TUMOR CELLS, CULTURED;

EID: 0032516798     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00138-6     Document Type: Article

References (30)

1. Baker, C.J., Edwards, M.S., 1990. Group B streptococcal infections. In: Remington, J.S., Klein, J.O. (Eds.), Infectious diseases of the fetus and newborn infant, 3rd edn., W.B. Saunders, PA, pp. 742-811.
2. Bilzer T., Stavrou D., Dahme E., Keiditsch E., Burrig K.F., Anzil A.P., Wechsler W. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows Arch. A. Pathol. Anat. Histopathol. 418:1991;281-293.
3. Braun M.A., Gerlach D., Hartwig U.F., Ozegowski J.H., Romagne F., Carrel S., Kohler W., Fleischer B. Stimulation of human T cells by streptococcal 'superantigen' erythrogenic toxins (scarlet fever toxins). J. Immunol. 150:1993;2457-2466.
4. Brouwers P., Heyes M.P., Moss H.A., Wolters P.L., Poplack D.G., Markey S.P., Pizzo P.A. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J. Infect. Dis. 168:1993;1380-1386.
5. Carlin J.M., Borden E.C., Byrne G.I. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J. Interferon Res. 9:1989;329-337.
6. Däubener W., Hadding U. Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system. Med. Microbiol. Immunol. Berl. 185:1997;195-206.
7. Däubener W., Pilz K., Seghrouchni Z.S., Bilzer T., Fischer H.G., Hadding U. Induction of toxoplasmostasis in a human glioblastoma by interferon gamma. J. Neuroimmunol. 43:1993;31-38.
8. Däubener W., Remscheid C., Nockemann S., Pilz K., Seghrouchni S., Mackenzie C., Hadding U. Anti-parasitic effector mechanisms in human brain tumor cells - role of interferon-gamma and tumor necrosis factor-alpha. Eur. J. Immunol. 26:1996;487-492.
9. Däubener W., Zennati S.S., Wernet P., Bilzer T., Fischer H.G., Hadding U. Human glioblastoma cell line 86HG39 activates T cells in an antigen specific major histocompatibility complex class II-dependent manner. J. Neuroimmunol. 41:1992;21-28.
10. de Groot C.J., Ruuls S.R., Theeuwes J.W., Dijkstra C.D., Van-der V.P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:1997;10-20.
11. el Mohandes A.E., Brudno D.S., Ahronovich M.D. Impaired interferon-alpha enhancement of neonatal monocyte phagocytosis. Biol. Neonate. 58:1990;260-263.
12. Farley M.M., Harvey R.C., Stull T., Smith J.D., Schuchat A., Wenger J.D., Stephens D.S. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. New Engl. J. Med. 328:1993;1807-1811. see comments.
13. Farrar M.A., Schreiber R.D. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:1993;571-611.
14. Fenton M.J., Vermeulen M.W., Kim S., Burdick M., Strieter R.M., Kornfeld H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65:1997;5149-5156.
15. Flohr T., Bange F.C., von E.A., Kiekenbeck M., Bottger E.C. Depletion of tryptophan is not involved in expression of tryptophanyl-tRNA synthetase mediated by interferon. Infect. Immun. 60:1992;4418-4421.
16. Fontana A., Frei K., Bodmer S., Hofer E. Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue. Immunol. Rev. 100:1987;185-201.
17. Fontana A., Grob P.J. Astrocyte-derived interleukin-1-like factors. Lymphokine Res. 3:1984;11-16.
18. Gisslen M., Larsson M., Norkrans G., Fuchs D., Wachter H., Hagberg L. Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection. AIDS Res. Hum. Retroviruses. 10:1994;947-951.
19. Goodrum K.J., Dierksheide J., Yoder B.J. Tumor necrosis factor alpha acts as an autocrine second signal with gamma interferon to induce nitric oxide in group B streptococcus-treated macrophages. Infect. Immun. 63:1995;3715-3717.
20. Lee S.C., Dickson D.W., Liu W., Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J. Neuroimmunol. 46:1993;19-24.
21. Peterson P.K., Gekker G., Hu S., Chao C.C. Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. J. Infect. Dis. 168:1993;1472-1478.
22. Peterson P.K., Gekker G., Hu S., Chao C.C. Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. J. Infect. Dis. 171:1995;516-518. letter.
23. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U.S.A. 81:1984;908-912.
24. Pfefferkorn E.R., Eckel M., Rebhun S. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol. Biochem. Parasitol. 20:1986;215-224.
25. Schwartzman J.D., Gonias S.L., Pfefferkorn E.R. Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts. Infect. Immun. 58:1990;833-834.
26. Taylor S., Bryson Y.J. Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J. Immunol. 134:1985;1493-1497.
27. Valentin-Weigand P., Benkel P., Rohde M., Chhatwal G.S. Entry and intracellular survival of group B streptococci in J774 macrophages. Infect. Immun. 64:1996;2467-2473.
28. Vallejo J.G., Baker C.J., Edwards M.S. Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci. J. Infect. Dis. 174:1996;332-337.
29. Weigent D.A., Huff T.L., Peterson J.W., Stanton G.J., Baron S. Role of interferon in streptococcal infection in the mouse. Microb. Pathog. 1:1986;399-407.
30. Widner B., Werner E.R., Schennach H., Wachter H., Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43:1997;2424-2426.